Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-151200CALL0 054.8TRUE00
2025-08-151250CALL0 057.42TRUE00
2025-08-151300CALL0 055.82TRUE00
2025-08-151350CALL0 061.98TRUE00
2025-08-1514035.83CALL0 2054.12TRUE00
2025-08-1514531.33CALL0 2060.22TRUE00
2025-08-1515024CALL0 159.65TRUE00
2025-08-1515520CALL0 259.81TRUE00
2025-08-151600CALL0 056.91TRUE00
2025-08-151650CALL0 056.05TRUE00
2025-08-1517013.15CALL0 255.88FALSE00
2025-08-151759.1CALL76 5360.16FALSE9.10
2025-08-151809.4CALL0 3257.06FALSE00
2025-08-151854.85CALL53 1255FALSE4.850
2025-08-151906.34CALL0 5053.91FALSE00
2025-08-151953.34CALL0 253.64FALSE00
2025-08-152003.35CALL0 1353.38FALSE00
2025-08-152101.6CALL1 261.5FALSE1.60
2025-08-152200.75CALL0 265.23FALSE00
2025-08-152300CALL0 072.32FALSE00
2025-08-152400CALL0 079.88FALSE00
2025-08-152500CALL0 086.96FALSE00
2025-08-152600CALL0 093.62FALSE00
2025-08-151200PUT0 088.91FALSE00
2025-08-151250PUT0 081.36FALSE00
2025-08-151300PUT0 074.28FALSE00
2025-08-151350PUT0 067.88FALSE00
2025-08-151400PUT0 061.88FALSE00
2025-08-151450PUT0 059.07FALSE00
2025-08-151501.84PUT0 256.59FALSE00
2025-08-151555PUT2 762.7FALSE1.850.59
2025-08-151602.25PUT1 22160.5FALSE-2.3-0.51
2025-08-151655.84PUT0 113958.59FALSE00
2025-08-151707.55PUT0 1255.36TRUE00
2025-08-1517510.6PUT3 143.24TRUE0.30.03
2025-08-151800PUT0 054.29TRUE00
2025-08-151850PUT0 052.26TRUE00
2025-08-151900PUT0 051.8TRUE00
2025-08-1519522.9PUT0 151.47TRUE00
2025-08-152000PUT0 051.28TRUE00
2025-08-1521035.3PUT0 050.6TRUE00
2025-08-152200PUT0 075.08TRUE00
2025-08-152300PUT0 063.22TRUE00
2025-08-152400PUT0 070.34TRUE00
2025-08-152500PUT0 073.35TRUE00
2025-08-152600PUT0 079.53TRUE00
2025-09-19750CALL0 0139.74TRUE00
2025-09-19800CALL0 0128.15TRUE00
2025-09-19850CALL0 0121.64TRUE00
2025-09-19900CALL0 068.43TRUE00
2025-09-19950CALL0 066.61TRUE00
2025-09-191000CALL0 056.68TRUE00
2025-09-191050CALL0 063.68TRUE00
2025-09-191100CALL0 058.7TRUE00
2025-09-191150CALL0 061.08TRUE00
2025-09-191200CALL0 062.08TRUE00
2025-09-191250CALL0 062.27TRUE00
2025-09-191300CALL0 058.43TRUE00
2025-09-191350CALL0 061.05TRUE00
2025-09-1914035.5CALL0 159.83TRUE00
2025-09-191450CALL0 059.01TRUE00
2025-09-1915028CALL0 156.61TRUE00
2025-09-1915524.55CALL0 156.46TRUE00
2025-09-191600CALL0 055.31TRUE00
2025-09-1916522.6CALL0 154.77TRUE00
2025-09-1917020CALL218 10054.59FALSE200
2025-09-1917515.82CALL0 454.2FALSE00
2025-09-1918016.1CALL0 1053.64FALSE00
2025-09-1918512CALL196 21053.31FALSE120
2025-09-191908.48CALL6 154.91FALSE8.480
2025-09-191958.45CALL0 152.82FALSE00
2025-09-192007.2CALL0 56852.83FALSE00
2025-09-192104.59CALL0 151.99FALSE00
2025-09-192200CALL0 053.41FALSE00
2025-09-192301.95CALL0 254.19FALSE00
2025-09-192401.2CALL0 50057.15FALSE00
2025-09-192500.8CALL0 160.94FALSE00
2025-09-192600.35CALL0 164.03FALSE00
2025-09-19750PUT0 0119.95FALSE00
2025-09-19800PUT0 0111.59FALSE00
2025-09-19850PUT0 0103.74FALSE00
2025-09-19900PUT0 096.33FALSE00
2025-09-19950PUT0 089.74FALSE00
2025-09-191000PUT0 083.84FALSE00
2025-09-191050PUT0 078.12FALSE00
2025-09-191100PUT0 072.9FALSE00
2025-09-191150PUT0 068.37FALSE00
2025-09-191200PUT0 060.71FALSE00
2025-09-191250PUT0 058.68FALSE00
2025-09-191300PUT0 056.61FALSE00
2025-09-191352.6PUT0 159FALSE00
2025-09-191403.3PUT0 156.8FALSE00
2025-09-191450PUT0 056.23FALSE00
2025-09-191505.7PUT0 101053.52FALSE00
2025-09-191556.4PUT0 255.82FALSE00
2025-09-191609.2PUT0 2054.61FALSE00
2025-09-1916511PUT4 22150.29FALSE-0.3-0.03
2025-09-1917013.1PUT202 15048.84TRUE0.10.01
2025-09-1917514.3PUT0 352.32TRUE00
2025-09-1918016.5PUT0 1351.78TRUE00
2025-09-1918520.4PUT0 351.79TRUE00
2025-09-1919022.8PUT0 151.49TRUE00
2025-09-191950PUT0 051.94TRUE00
2025-09-192000PUT0 052.5TRUE00
2025-09-192100PUT0 052.43TRUE00
2025-09-192200PUT0 051.38TRUE00
2025-09-192300PUT0 051.42TRUE00
2025-09-192400PUT0 053.78TRUE00
2025-09-192500PUT0 057.14TRUE00
2025-09-192600PUT0 060.8TRUE00
2025-10-17750CALL0 0116.97TRUE00
2025-10-17800CALL0 0109.59TRUE00
2025-10-17850CALL0 064.17TRUE00
2025-10-17900CALL0 061.35TRUE00
2025-10-17950CALL0 061.25TRUE00
2025-10-171000CALL0 056.43TRUE00
2025-10-171050CALL0 057.74TRUE00
2025-10-171100CALL0 057.22TRUE00
2025-10-171150CALL0 057.27TRUE00
2025-10-171200CALL0 057.02TRUE00
2025-10-171250CALL0 055.49TRUE00
2025-10-171300CALL0 054.27TRUE00
2025-10-171350CALL0 054.71TRUE00
2025-10-171400CALL0 054.37TRUE00
2025-10-171450CALL0 056.21TRUE00
2025-10-171500CALL0 053.5TRUE00
2025-10-1715529.75CALL0 754.12TRUE00
2025-10-171600CALL0 052.81TRUE00
2025-10-171650CALL0 051.67TRUE00
2025-10-1717021.5CALL0 651.11FALSE00
2025-10-171750CALL0 050.78FALSE00
2025-10-1718013.8CALL0 350.11FALSE00
2025-10-1718512.8CALL0 149.39FALSE00
2025-10-171900CALL0 048.96FALSE00
2025-10-171950CALL0 051.11FALSE00
2025-10-172007CALL11 28148.37FALSE-1.93-0.22
2025-10-172104.6CALL0 148.34FALSE00
2025-10-172200CALL0 247.98FALSE00
2025-10-172300CALL0 247.94FALSE00
2025-10-172402.3CALL1 151.59FALSE2.30
2025-10-172501.55CALL1 150.81FALSE1.550
2025-10-172601.05CALL1 150.33FALSE1.050
2025-10-17750PUT0 099.91FALSE00
2025-10-17800PUT0 093.4FALSE00
2025-10-17850PUT0 086.86FALSE00
2025-10-17900PUT0 081.44FALSE00
2025-10-17950PUT0 076.24FALSE00
2025-10-171000PUT0 071.23FALSE00
2025-10-171050PUT0 166.97FALSE00
2025-10-171100PUT0 163.26FALSE00
2025-10-171150PUT0 059.95FALSE00
2025-10-171200PUT0 056.09FALSE00
2025-10-171250PUT0 255.38FALSE00
2025-10-171300PUT0 253.74FALSE00
2025-10-171356PUT0 153.1FALSE00
2025-10-171400PUT0 054.48FALSE00
2025-10-171450PUT0 052.91FALSE00
2025-10-171500PUT0 051.89FALSE00
2025-10-171550PUT0 051.73FALSE00
2025-10-171600PUT0 051.14FALSE00
2025-10-171650PUT0 050.32FALSE00
2025-10-171700PUT0 050.32TRUE00
2025-10-1717517.25PUT0 049.77TRUE00
2025-10-171800PUT0 049.29TRUE00
2025-10-171850PUT0 049.35TRUE00
2025-10-171900PUT0 048.14TRUE00
2025-10-171950PUT0 048.5TRUE00
2025-10-172000PUT0 048.46TRUE00
2025-10-172100PUT0 048.67TRUE00
2025-10-172200PUT0 047.03TRUE00
2025-10-172300PUT0 046.09TRUE00
2025-10-1724070PUT0 348.69TRUE00
2025-10-172500PUT0 061.29TRUE00
2025-10-172600PUT0 054.19TRUE00
2025-12-19600CALL0 066.91TRUE00
2025-12-19650CALL0 062.72TRUE00
2025-12-19700CALL0 055.08TRUE00
2025-12-19750CALL0 157.51TRUE00
2025-12-19800CALL0 058.58TRUE00
2025-12-19850CALL0 060.69TRUE00
2025-12-19900CALL0 059.42TRUE00
2025-12-19950CALL0 058.75TRUE00
2025-12-191000CALL0 058.3TRUE00
2025-12-191050CALL0 058.6TRUE00
2025-12-191100CALL0 058.33TRUE00
2025-12-191150CALL0 058.18TRUE00
2025-12-191200CALL0 056.01TRUE00
2025-12-191250CALL0 3856.94TRUE00
2025-12-191300CALL0 156.15TRUE00
2025-12-191350CALL0 155.27TRUE00
2025-12-191400CALL0 355.52TRUE00
2025-12-1914545.54CALL0 255.08TRUE00
2025-12-1915037.5CALL0 254.75TRUE00
2025-12-191550CALL0 053.99TRUE00
2025-12-191600CALL0 6653.22TRUE00
2025-12-191650CALL0 053.16TRUE00
2025-12-1917026.5CALL0 7152.59FALSE00
2025-12-1917526CALL0 552.11FALSE00
2025-12-1918022.49CALL0 1251.95FALSE00
2025-12-1918521.7CALL0 2051.79FALSE00
2025-12-1919020.5CALL0 550.94FALSE00
2025-12-1919516.6CALL0 6050.91FALSE00
2025-12-1920018CALL0 5551.15FALSE00
2025-12-1921014.2CALL0 1150.15FALSE00
2025-12-192209.3CALL0 6550.01FALSE00
2025-12-192300CALL0 049.65FALSE00
2025-12-192408.7CALL0 249.5FALSE00
2025-12-192504.7CALL0 348.75FALSE00
2025-12-192602.4CALL0 248.16FALSE00
2025-12-19600PUT0 095.71FALSE00
2025-12-19650PUT0 189.45FALSE00
2025-12-19700PUT0 083.66FALSE00
2025-12-19750PUT0 078.27FALSE00
2025-12-19800PUT0 2073.52FALSE00
2025-12-19850PUT0 169.32FALSE00
2025-12-19900PUT0 2165.79FALSE00
2025-12-19950PUT0 162.55FALSE00
2025-12-191000PUT0 159.3FALSE00
2025-12-191050PUT0 157FALSE00
2025-12-191101.8PUT0 355.81FALSE00
2025-12-191152.5PUT0 156.88FALSE00
2025-12-191203.4PUT0 356.51FALSE00
2025-12-191250PUT0 156.28FALSE00
2025-12-191300PUT0 155.12FALSE00
2025-12-191350PUT0 155.74FALSE00
2025-12-191400PUT0 055.11FALSE00
2025-12-191450PUT0 154.61FALSE00
2025-12-191500PUT0 054.09FALSE00
2025-12-191550PUT0 053.66FALSE00
2025-12-191600PUT0 053.05FALSE00
2025-12-191650PUT0 052.41FALSE00
2025-12-1917018.7PUT0 11051.86TRUE00
2025-12-191750PUT0 051.72TRUE00
2025-12-191800PUT0 051.55TRUE00
2025-12-1918527.5PUT0 16649.51TRUE00
2025-12-191900PUT0 050.55TRUE00
2025-12-191950PUT0 050.09TRUE00
2025-12-192000PUT0 1650.35TRUE00
2025-12-192100PUT0 149.53TRUE00
2025-12-1922051.9PUT0 349.21TRUE00
2025-12-192300PUT0 049.16TRUE00
2025-12-192400PUT0 148.66TRUE00
2025-12-192500PUT0 047.4TRUE00
2025-12-1926086PUT0 145.08TRUE00
2026-01-16750CALL0 058.9TRUE00
2026-01-16800CALL0 059.64TRUE00
2026-01-16850CALL0 059.69TRUE00
2026-01-16900CALL0 059.81TRUE00
2026-01-16950CALL0 058.63TRUE00
2026-01-161000CALL0 058.09TRUE00
2026-01-161050CALL0 059.59TRUE00
2026-01-161100CALL0 057.27TRUE00
2026-01-161150CALL0 056.87TRUE00
2026-01-161200CALL0 056.35TRUE00
2026-01-161250CALL0 056.63TRUE00
2026-01-161300CALL0 055.37TRUE00
2026-01-161350CALL0 055.31TRUE00
2026-01-161400CALL0 054.94TRUE00
2026-01-161450CALL0 054.43TRUE00
2026-01-1615037.5CALL0 053.06TRUE00
2026-01-161550CALL0 052.25TRUE00
2026-01-1616035.98CALL0 652.04TRUE00
2026-01-1616524.85CALL0 2151.46TRUE00
2026-01-1617029.9CALL0 851.22FALSE00
2026-01-1617525.7CALL0 650.75FALSE00
2026-01-161800CALL0 550.19FALSE00
2026-01-1618521.25CALL0 1649.95FALSE00
2026-01-1619017.9CALL2 350.57FALSE17.90
2026-01-1619518.9CALL0 450.07FALSE00
2026-01-1620019.05CALL0 349.07FALSE00
2026-01-1621016.16CALL0 349.55FALSE00
2026-01-162209.5CALL0 048.74FALSE00
2026-01-1623010CALL0 348.69FALSE00
2026-01-162407.2CALL0 148.35FALSE00
2026-01-162507.7CALL0 248.54FALSE00
2026-01-162600CALL0 047.94FALSE00
2026-01-16750PUT0 073.72FALSE00
2026-01-16800PUT0 069.51FALSE00
2026-01-16850PUT0 066FALSE00
2026-01-16900PUT0 063.01FALSE00
2026-01-16950PUT0 059.8FALSE00
2026-01-161000PUT0 059.07FALSE00
2026-01-161050PUT0 056.33FALSE00
2026-01-161100PUT0 056.46FALSE00
2026-01-161150PUT0 056.7FALSE00
2026-01-161200PUT0 055.89FALSE00
2026-01-161250PUT0 055.12FALSE00
2026-01-161300PUT0 554.28FALSE00
2026-01-161350PUT0 2754.27FALSE00
2026-01-161400PUT0 1953.24FALSE00
2026-01-161450PUT0 1453.05FALSE00
2026-01-1615018.6PUT0 152.2FALSE00
2026-01-161550PUT0 051.25FALSE00
2026-01-161600PUT0 050.88FALSE00
2026-01-1616518.6PUT6 1648.07FALSE18.60
2026-01-1617020.3PUT9 050.07TRUE20.30
2026-01-161750PUT0 049.31TRUE00
2026-01-161800PUT0 049.38TRUE00
2026-01-1618527.9PUT0 548.69TRUE00
2026-01-1619032.1PUT2 049.28TRUE32.10
2026-01-161950PUT0 048.49TRUE00
2026-01-162000PUT0 048.26TRUE00
2026-01-162100PUT0 048.15TRUE00
2026-01-162200PUT0 048.13TRUE00
2026-01-162300PUT0 047.86TRUE00
2026-01-162400PUT0 046.95TRUE00
2026-01-162500PUT0 047.77TRUE00
2026-01-162600PUT0 046.29TRUE00
2026-06-18800CALL0 057.21TRUE00
2026-06-18850CALL0 058.17TRUE00
2026-06-18900CALL0 058.3TRUE00
2026-06-18950CALL0 057.88TRUE00
2026-06-181000CALL0 058.01TRUE00
2026-06-181050CALL0 056.87TRUE00
2026-06-181100CALL0 056.29TRUE00
2026-06-181150CALL0 055.99TRUE00
2026-06-181200CALL0 055.65TRUE00
2026-06-181250CALL0 055.62TRUE00
2026-06-181300CALL0 055.86TRUE00
2026-06-181350CALL0 054.44TRUE00
2026-06-181400CALL0 1054.29TRUE00
2026-06-181450CALL0 053.44TRUE00
2026-06-181500CALL0 053.06TRUE00
2026-06-1815551.5CALL0 252.66TRUE00
2026-06-1816049CALL0 251.99TRUE00
2026-06-1816538.61CALL0 251.5TRUE00
2026-06-1817037CALL2 853.52FALSE370
2026-06-181750CALL0 050.81FALSE00
2026-06-181800CALL0 050.61FALSE00
2026-06-1818531.8CALL0 150.33FALSE00
2026-06-181900CALL0 049.9FALSE00
2026-06-181950CALL0 049.71FALSE00
2026-06-1820025.8CALL0 349.3FALSE00
2026-06-1821024.9CALL0 248.67FALSE00
2026-06-1822021.8CALL0 147.75FALSE00
2026-06-1823018.6CALL0 446.36FALSE00
2026-06-182400CALL0 045.78FALSE00
2026-06-1825013.5CALL0 145.44FALSE00
2026-06-182600CALL0 045.22FALSE00
2026-06-18800PUT0 058.45FALSE00
2026-06-18850PUT0 056.34FALSE00
2026-06-18900PUT0 054.81FALSE00
2026-06-18950PUT0 054.22FALSE00
2026-06-181000PUT0 053.68FALSE00
2026-06-181050PUT0 053.57FALSE00
2026-06-181100PUT0 054.29FALSE00
2026-06-181150PUT0 054.22FALSE00
2026-06-181200PUT0 054.06FALSE00
2026-06-181250PUT0 053.59FALSE00
2026-06-181300PUT0 253.2FALSE00
2026-06-181350PUT0 052.46FALSE00
2026-06-181400PUT0 052.41FALSE00
2026-06-181450PUT0 052.86FALSE00
2026-06-181500PUT0 052.39FALSE00
2026-06-1815522.5PUT0 152.17FALSE00
2026-06-181600PUT0 051.31FALSE00
2026-06-181650PUT0 050.87FALSE00
2026-06-181700PUT0 050.41TRUE00
2026-06-1817532PUT0 4050.16TRUE00
2026-06-1818033.3PUT5 447.53TRUE33.30
2026-06-1818536.1PUT0 649.37TRUE00
2026-06-181900PUT0 049.39TRUE00
2026-06-181950PUT0 048.92TRUE00
2026-06-1820044.5PUT0 248.67TRUE00
2026-06-182100PUT0 048.12TRUE00
2026-06-182200PUT0 047.3TRUE00
2026-06-182300PUT0 047.15TRUE00
2026-06-182400PUT0 046.38TRUE00
2026-06-182500PUT0 046.42TRUE00
2026-06-1826090.48PUT0 26945.89TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm